Annual report [Section 13 and 15(d), not S-K Item 405]

Document and Entity Information

v3.25.0.1
Document and Entity Information - USD ($)
 12 Months Ended
Dec. 31, 2024
Mar. 11, 2025
Jun. 30, 2024
Document Information [Line Items]      
Document Type 10-K    
Amendment Flag false    
Document Period End Date Dec. 31, 2024    
Document Fiscal Year Focus 2024    
Document Fiscal Period Focus FY    
Document Transition Report false    
Document Annual Report true    
Trading Symbol ACHV    
Entity Incorporation, State or Country Code DE    
Entity Registrant Name Achieve Life Sciences, Inc.    
Entity Central Index Key 0000949858    
Current Fiscal Year End Date --12-31    
Entity Well-known Seasoned Issuer No    
Entity Current Reporting Status Yes    
Entity Interactive Data Current Yes    
Entity Voluntary Filers No    
Entity Filer Category Non-accelerated Filer    
Entity Shell Company false    
Entity Small Business true    
Entity Emerging Growth Company false    
Entity File Number 033-80623    
Entity Tax Identification Number 95-4343413    
Entity Address, Address Line One 1040 West Georgia Street    
Entity Address, Address Line Two Suite 1030    
Entity Address, City or Town Vancouver    
Entity Address, State or Province BC    
Entity Address, Postal Zip Code V6E 4H1    
City Area Code 604    
Local Phone Number 210-2217    
Entity Common Stock, Shares Outstanding   34,685,072  
Entity Public Float     $ 144,081,005
Title of 12(b) Security Common Stock, par value $0.001 per share    
Security Exchange Name NASDAQ    
ICFR Auditor Attestation Flag false    
Auditor Firm ID 271    
Auditor Name PricewaterhouseCoopers LLP    
Auditor Location Vancouver, Canada    
Documents Incorporated by Reference

Portions of the Registrant’s Definitive Proxy Statement for its 2025 Annual Meeting of Stockholders (“Proxy Statement”), to be filed within 120 days of the Registrant’s fiscal year ended December 31, 2024, is incorporated by reference into Part III of this Annual Report on Form 10-K.

    
Document Financial Statement Error Correction [Flag] false    
Auditor Opinion We have audited the accompanying consolidated balance sheets of Achieve Life Sciences, Inc. and its subsidiaries (the Company) as of December 31, 2024 and 2023, and the related consolidated statements of loss and comprehensive loss, of stockholders’ equity and of cash flows for each of the three years in the period ended December 31, 2024, including the related notes (collectively referred to as the consolidated financial statements). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2024 and 2023, and the results of its operations and its cash flows for each of the three years in the period ended December 31, 2024 in conformity with accounting principles generally accepted in the United States of America    
Other Address      
Document Information [Line Items]      
Entity Address, Address Line One 22722 29th Drive SE    
Entity Address, Address Line Two Suite 100    
Entity Address, City or Town Bothell    
Entity Address, State or Province WA    
Entity Address, Postal Zip Code 98021